A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples
- 16 February 2011
- journal article
- research article
- Published by Hindawi Limited in Andrologia
- Vol. 44 (2) , 78-85
Abstract
Prompted by the recently reported expression of POU5F1 (OCT3/4) in epididymis, a panel of markers for carcinoma in situ (CIS) testis and testicular germ cell tumours (TGCT), including AP-2γ(TFAP2C), NANOG, OCT3/4, KIT, placental-like alkaline phosphatase (PLAP), M2A/PDPN and MAGE-A4 were examined by immunohistochemistry or in situ hybridisation in urogenital epithelia, which may interfere with detection of CIS cells in semen. In addition to OCT3/4, the expression of AP-2γ and NANOG or their variants was detected in urogenital epithelia, while other CIS markers, including PLAP/alkaline phosphatase were absent. A combination of immunocytological staining for AP-2γ or OCT3/4 and rapid cytochemical alkaline phosphatase reaction was subsequently developed. This approach was tested in 22 patients with TGCT. In 14 patients (63.6%), double stained cells were found and thus the method was proven suitable for the detection of CIS cells in semen. In conclusion, transcription factors related to pluripotency and undifferentiated state of cells, which most likely have several variants or modifications, are unexpectedly detected using currently available antibodies in urogenital epithelial cells which may be shed into semen. Combining the immunohistochemical nuclear markers with a rapid cytochemical alkaline phosphatase reaction for detection of CIS cells in ejaculates may provide a more reliable diagnostic method.Keywords
This publication has 24 references indexed in Scilit:
- OCT4 and downstream factors are expressed in human somatic urogenital epithelia and in culture of epididymal spheresMolecular Human Reproduction, 2010
- The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasiaThe Prostate, 2009
- KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literatureInternational Journal of Andrology, 2007
- CDH1 (E‐cadherin) in testicular germ cell neoplasia: suppressed translation of mRNA in pre‐invasive carcinoma in situ but increased protein levels in advanced tumoursAPMIS, 2006
- PREVALENCE OF TESTICULAR INTRAEPITHELIAL NEOPLASIA IN HEALTHY MALESJournal of Urology, 2005
- Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAsCell, 2004
- The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE‐A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminomaHistopathology, 2003
- Effect of Graded Testicular Doses of Radiotherapy in Patients Treated for Carcinoma-In-Situ in the TestisJournal of Clinical Oncology, 2002
- A new approach using tissue alkaline phosphatase activity to identify early testicular cancerBritish Journal of Urology, 1997
- RADIATION TREATMENT OF CARCINOMA-IN-SITU OF TESTISThe Lancet, 1986